Floatz logo

Adenovirus Specific T- Lymphocytes

Cytomegalovirus Infections

Jessie L. AlexanderCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Cytomegalovirus Infections cohort.

Asset / SponsorPhaseRating
Foscarnet
City of Hope Medical Center
Phase 4BB
Valganciclovir
The Methodist Hospital Research Institute
Phase 3BB
Ganciclovir
City of Hope Medical Center
Phase 3BB
Cmvpp65-A*0201 Peptide Vaccine
City of Hope Medical Center
Phase 2B
Letermovir
Fernanda P Silveira, MD, MS
Phase 2B

View all 16 →

Same molecule, other indications

Adenovirus Specific T- Lymphocytes is also rated in:

adenoviridae infectious diseaseDormant
CCC
Indicative ·
48 / 100
View asset →
Epstein-Barr virus infectionDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →